Insider Buying: Proteome Sciences plc (PRM) Insider Purchases £9,418.71 in Stock

Proteome Sciences plc (LON:PRM) insider Martin Diggle purchased 313,957 shares of Proteome Sciences stock in a transaction that occurred on Thursday, November 8th. The shares were bought at an average price of GBX 3 ($0.04) per share, for a total transaction of £9,418.71 ($12,307.21).

Shares of LON:PRM opened at GBX 3.48 ($0.05) on Thursday. Proteome Sciences plc has a 12-month low of GBX 2.61 ($0.03) and a 12-month high of GBX 5.64 ($0.07).

Separately, FinnCap reiterated a “corporate” rating on shares of Proteome Sciences in a report on Tuesday, November 6th.

COPYRIGHT VIOLATION WARNING: This piece was published by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, biomarker assays, isobaric and isotopic reagents, and proprietary biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes.

Read More: What do investors mean by earnings per share?

Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit